Jul 29, 2026 08:00AM
Jul 27, 2026 08:00AM
Jul 21, 2026 08:02AM
Jul 21, 2026 08:00AM
Jul 15, 2026 08:00AM
May 27, 2026 08:00AM
Apr 21, 2026 08:00AM PharmaTher Highlights Strategic Ketamine Opportunity Following New U.S. Executive Order on Psychedelic Treatments for Serious Mental Illness
Apr 20, 2026 08:00AM
Apr 16, 2026 08:00AM
Mar 3, 2026 08:00AM
Feb 2, 2026 09:27AM
Jan 14, 2026 08:00AM
Jan 2, 2026 08:00AM
Dec 2, 2025 09:53AM PharmaTher Closes Sale of Ketamine ANDA, Sharpening Focus on Long-Acting Injectable Ketamine Franchise
Nov 17, 2025 08:00AM
Oct 17, 2025 08:26AM
Oct 16, 2025 08:04AM
Oct 16, 2025 08:00AM
Oct 15, 2025 08:00AM
Oct 8, 2025 08:00AM
Aug 27, 2025 08:00AM PharmaTher Advances Ketamine Patch as Non-Opioid Pain Relief Solution Leveraging FDA Approved IV Ketamine (KETARx(TM)), Aligned with FDA's CNPV National Priority Initiative
Aug 14, 2025 08:02AM
Aug 14, 2025 08:00AM
Aug 11, 2025 09:51AM
Aug 11, 2025 09:49AM
Aug 11, 2025 09:26AM
Aug 11, 2025 09:26AM
Jun 18, 2025 08:00AM PharmaTher Applauds FDA's New Commissioner’s National Priority Voucher (CNPV) Program, Citing Potential to Accelerate its Ketamine Programs for Mental Health, Pain, and Neurological Disorders,
Mar 3, 2025 08:00AM
Sep 19, 2024 08:00AM
Aug 28, 2024 08:00AM
Aug 19, 2024 08:00AM
May 15, 2024 08:00AM
May 1, 2024 08:50AM
May 2, 2023 07:30AM PharmaTher Holdings Submits Fast Track Application to FDA for KETARX™ (Ketamine) for the Treatment of Parkinson’s Disease
Apr 3, 2023 07:00AM
Mar 29, 2023 07:30AM
Feb 7, 2023 07:59AM
Feb 6, 2023 08:00AM
Feb 2, 2023 07:30AM
Feb 1, 2023 11:25AM
Jan 18, 2023 08:15AM PharmaTher Holdings Submits for FDA Orphan Drug Designation for Ketamine to Treat Rett Syndrome
Jan 11, 2023 08:15AM
Dec 15, 2022 07:59AM
Nov 14, 2022 07:59AM
Nov 1, 2022 07:00AM
Oct 5, 2022 07:00AM
Sep 29, 2022 07:00AM
Sep 16, 2022 07:00AM PharmaTher Announces Late-Breaking Abstract Presentation of Positive Efficacy and Safety Data from Phase 1/2 Clinical Study of Ketamine in the Treatment of Levodopa-Induced Dyskinesia in Parkinson’s
Sep 7, 2022 07:00AM

327,780 total articles have been posted to this entity.

Click Here to Sign-Up for StreetInsider.com Premium to View All